Skip to main content

Affinity Asset Advisors, LLC

SEC CIK
0001773195
Latest filing
Aug 13, 2026

CRSP holding history

CRISPR Therapeutics AG in every 13F filed by Affinity Asset Advisors, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

CRSP overviewAll 13F holders of CRSPFull Q2 2026 holdings

Shares (Q2 2026)
100,000
Value
$5.45M
% of portfolio
0.3%
Quarters held
2
Since Q1 2026
Holdings of CRSP by Affinity Asset Advisors, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026100,000$5.45M0.3%−50,000−33.3%ReducedHolders
Q1 2026150,000$7.14M0.4%+150,000NewHolders